These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26088817)

  • 21. Scleroderma dermal microvascular endothelial cells exhibit defective response to pro-angiogenic chemokines.
    Tsou PS; Rabquer BJ; Ohara RA; Stinson WA; Campbell PL; Amin MA; Balogh B; Zakhem G; Renauer PA; Lozier A; Arasu E; Haines GK; Kahaleh B; Schiopu E; Khanna D; Koch AE
    Rheumatology (Oxford); 2016 Apr; 55(4):745-54. PubMed ID: 26705326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fli1 deficiency contributes to the downregulation of endothelial protein C receptor in systemic sclerosis: a possible role in prothrombotic conditions.
    Saigusa R; Asano Y; Yamashita T; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
    Br J Dermatol; 2016 Feb; 174(2):338-47. PubMed ID: 26399195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis.
    Giusti B; Serratì S; Margheri F; Papucci L; Rossi L; Poggi F; Magi A; Del Rosso A; Cinelli M; Guiducci S; Kahaleh B; Matucci-Cerinic M; Abbate R; Fibbi G; Del Rosso M
    Arthritis Rheum; 2005 Nov; 52(11):3618-28. PubMed ID: 16255054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis.
    Manetti M; Guiducci S; Romano E; Avouac J; Rosa I; Ruiz B; Lepri G; Bellando-Randone S; Ibba-Manneschi L; Allanore Y; Matucci-Cerinic M
    Arthritis Res Ther; 2013 Oct; 15(5):R165. PubMed ID: 24286167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bosentan improves skin perfusion of hands in patients with systemic sclerosis with pulmonary arterial hypertension.
    Rosato E; Molinaro I; Borghese F; Rossi C; Pisarri S; Salsano F
    J Rheumatol; 2010 Dec; 37(12):2531-9. PubMed ID: 20810512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic down-regulation of microRNA-126 in scleroderma endothelial cells is associated with impaired responses to VEGF and defective angiogenesis.
    Wang Y; Sun J; Kahaleh B
    J Cell Mol Med; 2021 Jul; 25(14):7078-7088. PubMed ID: 34137496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of serum soluble Tie1 levels in patients with systemic sclerosis.
    Noda S; Asano Y; Aozasa N; Akamata K; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
    Arch Dermatol Res; 2013 May; 305(4):325-31. PubMed ID: 23233281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis.
    Servettaz A; Guilpain P; Goulvestre C; Chéreau C; Hercend C; Nicco C; Guillevin L; Weill B; Mouthon L; Batteux F
    Ann Rheum Dis; 2007 Sep; 66(9):1202-9. PubMed ID: 17363403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine.
    Cipriani P; Marrelli A; Benedetto PD; Liakouli V; Carubbi F; Ruscitti P; Alvaro S; Pantano I; Campese AF; Grazioli P; Screpanti I; Giacomelli R
    Angiogenesis; 2013 Jul; 16(3):595-607. PubMed ID: 23413114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosis.
    Ichimura Y; Asano Y; Akamata K; Takahashi T; Noda S; Taniguchi T; Toyama T; Aozasa N; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Sato S; Kadono T
    Arch Dermatol Res; 2014 May; 306(4):331-8. PubMed ID: 24292093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of apoptosis and fibrillin 1 expression in human dermal endothelial cells by scleroderma sera containing anti-endothelial cell antibodies.
    Ahmed SS; Tan FK; Arnett FC; Jin L; Geng YJ
    Arthritis Rheum; 2006 Jul; 54(7):2250-62. PubMed ID: 16802364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood flow in the hands of a predefined homogeneous systemic sclerosis population: the presence of digital ulcers and the improvement with bosentan.
    Meijs J; Voskuyl AE; Bloemsaat-Minekus JP; Vonk MC
    Rheumatology (Oxford); 2015 Feb; 54(2):262-9. PubMed ID: 25150178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum levels of galectin-3: possible association with fibrosis, aberrant angiogenesis, and immune activation in patients with systemic sclerosis.
    Taniguchi T; Asano Y; Akamata K; Noda S; Masui Y; Yamada D; Takahashi T; Ichimura Y; Toyama T; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
    J Rheumatol; 2012 Mar; 39(3):539-44. PubMed ID: 22247367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial dysfunction in systemic sclerosis.
    Altorok N; Wang Y; Kahaleh B
    Curr Opin Rheumatol; 2014 Nov; 26(6):615-20. PubMed ID: 25191994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early Endothelial Progenitor Cells (eEPCs) in systemic sclerosis (SSc) - dynamics of cellular regeneration and mesenchymal transdifferentiation.
    Patschan S; Tampe D; Müller C; Seitz C; Herink C; Müller GA; Zeisberg E; Zeisberg M; Henze E; Patschan D
    BMC Musculoskelet Disord; 2016 Aug; 17():339. PubMed ID: 27519706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum apelin levels: clinical association with vascular involvements in patients with systemic sclerosis.
    Aozasa N; Asano Y; Akamata K; Noda S; Masui Y; Yamada D; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):37-42. PubMed ID: 22112232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significant attenuation of macrovascular involvement by bosentan in a patient with diffuse cutaneous systemic sclerosis with multiple digital ulcers and gangrene.
    Ichimura Y; Asano Y; Hatano M; Tamaki Z; Takekoshi T; Kogure A; Tomita M; Kawashima T; Miyazaki M; Taniguchi T; Takahashi T; Mitsui H; Sugaya M; Yao A; Kinugawa K; Sato S
    Mod Rheumatol; 2011 Oct; 21(5):548-52. PubMed ID: 21547701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of serum growth differentiation factor-15 levels in systemic sclerosis: association with disease severity.
    Yanaba K; Asano Y; Tada Y; Sugaya M; Kadono T; Sato S
    Mod Rheumatol; 2012 Sep; 22(5):668-75. PubMed ID: 22160844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelin receptor blockade ameliorates vascular fragility in endothelial cell-specific Fli-1-knockout mice by increasing Fli-1 DNA binding ability.
    Akamata K; Asano Y; Yamashita T; Noda S; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Trojanowska M; Sato S
    Arthritis Rheumatol; 2015 May; 67(5):1335-44. PubMed ID: 25707716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of angiogenesis by platelets in systemic sclerosis patients.
    Hirigoyen D; Burgos PI; Mezzano V; Duran J; Barrientos M; Saez CG; Panes O; Mezzano D; Iruretagoyena M
    Arthritis Res Ther; 2015 Nov; 17():332. PubMed ID: 26584613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.